TY - JOUR
T1 - A simple proteinuria-based risk score predicts contrast-associated acute kidney injury after percutaneous coronary intervention
AU - Fujiwara, Wakaya
AU - Ishii, Hideki
AU - Sobue, Yoshihiro
AU - Shimizu, Shinya
AU - Ishiguro, Tomoya
AU - Yamada, Ryo
AU - Ueda, Sayano
AU - Nishimura, Hideto
AU - Niwa, Yudai
AU - Miyazaki, Akane
AU - Miyagi, Wataru
AU - Takahara, Shuhei
AU - Naruse, Hiroyuki
AU - Ishii, Junichi
AU - Kiyono, Ken
AU - Watanabe, Eiichi
AU - Izawa, Hideo
N1 - Funding Information:
We are grateful to all the staff of the laboratory, intensive care unit, and cardiac wards at Fujita Health University Bantane Hospital for their dedication and contribution. E.W. received lecture fees from Daiichi-Sankyo; HI received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Bayer Pharmaceutical Co., Ltd., Bristol-Myers Squibb Inc., Chugai Pharmaceutical Co., Ltd., Daiichi-Sankyo Pharma Inc., and MSD K. K.
Funding Information:
This research was funded by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (Grant Number 21K08140, EW) and Japan Agency for Medical Research and Development (Grant Number 20hk0102071h0001, EW).
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Contrast-associated acute kidney injury (CA-AKI) is a complication of percutaneous coronary intervention (PCI). Because proteinuria is a sentinel marker of renal dysfunction, we assessed its role in predicting CA-AKI in patients undergoing PCI. A total of 1,254 patients undergoing PCI were randomly assigned to a derivation (n = 840) and validation (n = 414) dataset. We identified the independent predictors of CA-AKI where CA-AKI was defined by the new criteria issued in 2020, by a multivariate logistic regression in the derivation dataset. We created a risk score from the remaining predictors. The discrimination and calibration of the risk score in the validation dataset were assessed by the area under the receiver-operating characteristic curves (AUC) and Hosmer–Lemeshow test, respectively. A total of 64 (5.1%) patients developed CA-AKI. The 3 variables of the risk score were emergency procedures, serum creatinine, and proteinuria, which were assigned 1 point each based on the correlation coefficient. The risk score demonstrated a good discriminative power (AUC 0.789, 95% CI 0.766–0.912) and significant calibration. It was strongly associated with the onset of CA-AKI (Cochran-Armitage test, p < 0.0001). Our risk score that included proteinuria was simple to obtain and calculate, and may be useful in assessing the CA-AKI risk before PCI.
AB - Contrast-associated acute kidney injury (CA-AKI) is a complication of percutaneous coronary intervention (PCI). Because proteinuria is a sentinel marker of renal dysfunction, we assessed its role in predicting CA-AKI in patients undergoing PCI. A total of 1,254 patients undergoing PCI were randomly assigned to a derivation (n = 840) and validation (n = 414) dataset. We identified the independent predictors of CA-AKI where CA-AKI was defined by the new criteria issued in 2020, by a multivariate logistic regression in the derivation dataset. We created a risk score from the remaining predictors. The discrimination and calibration of the risk score in the validation dataset were assessed by the area under the receiver-operating characteristic curves (AUC) and Hosmer–Lemeshow test, respectively. A total of 64 (5.1%) patients developed CA-AKI. The 3 variables of the risk score were emergency procedures, serum creatinine, and proteinuria, which were assigned 1 point each based on the correlation coefficient. The risk score demonstrated a good discriminative power (AUC 0.789, 95% CI 0.766–0.912) and significant calibration. It was strongly associated with the onset of CA-AKI (Cochran-Armitage test, p < 0.0001). Our risk score that included proteinuria was simple to obtain and calculate, and may be useful in assessing the CA-AKI risk before PCI.
UR - http://www.scopus.com/inward/record.url?scp=85134370507&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134370507&partnerID=8YFLogxK
U2 - 10.1038/s41598-022-16690-6
DO - 10.1038/s41598-022-16690-6
M3 - Article
C2 - 35853998
AN - SCOPUS:85134370507
SN - 2045-2322
VL - 12
JO - Scientific reports
JF - Scientific reports
IS - 1
M1 - 12331
ER -